Persisting neurologic sequelae of lithium carbonate therapy
Some doctors lack familiarity with compounded formulations or hold outdated views about weight loss medications stemming from earlier-generation drugs with poor tolerability profiles
These are weekly subcutaneous injections
On the same date, it became available exclusively to Consultants in Australia, New Zealand, Europe, the UK, Mexico, and Thailand
Phase III RECONNECT Trials FDA Approval Dataset The Phase III RECONNECT trials (RECONNECT-1 and RECONNECT-2) a pair of randomised, double-blind, placebo-controlled, multicentre studies enrolled approximately 1,247 premenopausal women with HSDD across North America and confirmed statistically significant improvements in the number of satisfying sexual events and reduction in distress from low sexual desire with bremelanotide 1.75 mg subcutaneous vs placebo
Just use this link to subscribe, no coupon needed